Administration of Exogenous Growth Hormone Is Associated with Changes in Plasma and Intracellular Mammary Amino Acid Profiles and Abundance of the Mammary Gland Amino Acid Transporter SLC3A2 in Mid-Lactation Dairy Cows
Authors:
- Miriama SciasciaMSMiriama Sciascia
- David PachecoDPDavid Pacheco
- Susan A. McCoardSMSusan A. McCoard
Open Access
- 30 July 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (7) , e0134323
Abstract
The objectives of this study were to (1) identify changes in plasma and mammary intracellular amino acid (AA) profiles in dairy cows treated with growth hormone (GH), and (2) evaluate the expression of mammary gland genes involved in the transport of AA identified in (1). Eight non-pregnant ( n = 4 per group) lactating dairy cows were treated with a single subcutaneous injection of either a slow-release formulation of commercially available GH (Lactotropin 500 mg) or physiological saline solution. Six days after treatment, cows were milked and blood collected from the jugular vein for the analysis of free AA in the plasma. Cows were euthanized and mammary tissue harvested. Treatment with GH increased milk, protein, fat and lactose yields, with no effect on dry matter intake. Plasma concentrations of lysine and group I AA decreased significantly, and arginine, methionine, tyrosine and arginine-family AA tended to decrease in GH-treated cows. Concentrations of intracellular glycine, serine and glutamate increased significantly, with a trend for decreased arginine observed in the mammary gland of GH-treated cows. A trend for increased concentrations of intracellular total AA, NEAA and arginine-family AA were observed in the mammary gland of GH-treated cows. Variance in the concentration of plasma methionine, tyrosine, valine, alanine, ornithine, BCAA, EAA was significantly different between treatments. Variance in the concentration of intracellular lysine, valine, glutamine, EAA and group II was significantly different between treatments. AA changes were associated with increased mRNA abundance of the mammary gland AA transporter SLC3A2. We propose that these changes occur to support increased milk protein and fatty acid production in the mammary gland of GH-treated cows via potential mTOR pathway signaling.Keywords
This publication has 36 references indexed in Scilit:
- TRIENNIAL LACTATION SYMPOSIUM: Mammary metabolism of amino acids in dairy cows1,2Journal of Animal Science, 2012
- Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino AcidsCell, 2010
- Initiation and elongation steps of mRNA translation are involved in the increase in milk protein yield caused by growth hormone administration during lactationJournal of Dairy Science, 2009
- Effect of recombinant bovine somatotropin on sheep milk production, composition and some hemato-biochemical componentsSmall Ruminant Research, 2005
- Response of dairy ewes in late lactation to recombinant bovine somatotropinSmall Ruminant Research, 1999
- Effects of recombinant bovine somatotropin on goat milk yield, composition and plasma metabolitesSmall Ruminant Research, 1995
- A review of bovine growth hormoneCanadian Journal of Animal Science, 1994
- Kinetics of Amino Acid Extraction by Lactating Mammary Glands in Control and Sometribove-Treated Holstein CowsJournal of Dairy Science, 1992
- Effects of Exogenous Growth Hormone on Milk Production and Nutrient Uptake by Muscle and Mammary Tissues of Dairy Cows in Mid-lactationAustralian Journal of Biological Sciences, 1987
- Effect of Exogenous Growth Hormone in Early and Late Lactation on Lactational Performance of Dairy CowsJournal of Dairy Science, 1983